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Abstract
Background: Default from multidrug-resistant tuberculosis (MDR-TB) treatment remains a major barrier to cure and
epidemic control. We sought to identify patient risk factors for default from MDR-TB treatment and high-risk time
periods for default in relation to hospitalization and transition to outpatient care.
Methods: We retrospectively analyzed a cohort of 225 patients who initiated MDR-TB treatment between 2007
through 2010 at a rural TB hospital in the Western Cape Province, South Africa.
Results: Fifty percent of patients were cured or completed treatment, 27% defaulted, 14% died, 4% failed treatment,
and 5% transferred out. Recent alcohol use was common (63% of patients). In multivariable proportional hazards
regression, older age (hazard ratio [HR]= 0.97 [95% confidence interval 0.94-0.99] per year of greater age), formal
housing (HR=0.38 [0.19-0.78]), and steady employment (HR=0.41 [0.19-0.90]) were associated with decreased risk
of default, while recent alcohol use (HR=2.1 [1.1-4.0]), recent drug use (HR=2.0 [1.0-3.6]), and Coloured (mixed
ancestry) ethnicity (HR=2.3 [1.1-5.0]) were associated with increased risk of default (P<0.05). Defaults occurred
throughout the first 18 months of the two-year treatment course but were especially frequent among alcohol users
after discharge from the initial four-to-five-month in-hospital phase of treatment, with the highest default rates
occurring among alcohol users within two months of discharge. Default rates during the first two months after
discharge were also elevated for patients who received care from mobile clinics.
Conclusions: Among patients who were not cured or did not complete MDR-TB treatment, the majority defaulted
from treatment. Younger, economically-unstable patients and alcohol and drug users were particularly at risk. For
alcohol users as well as mobile-clinic patients, the early outpatient treatment phase is a high-risk period for default
that could be targeted in efforts to increase treatment completion rates.
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Introduction
Globally and in South Africa, the proportion of multidrug-
resistant tuberculosis (MDR-TB) patients who successfully
complete treatment remains less than 50% [1,2]. Completion of
MDR-TB treatment is challenging due to its long duration
(18-24 months), high pill burden, requirement of injections, and
frequent side effects, leading many patients to default, defined
as stopping regular treatment for two months or more prior to
completing their treatment course. Default rates greater than
20% have been reported in South Africa [3,4]. The resulting
incomplete treatment is associated with high patient mortality
[5,6] and increasingly-resistant TB strains [7].
Identified risk factors for default from treatment of drug-
sensitive (DS) TB include alcoholism and other substance
abuse, low socioeconomic indicators, and health systems
factors such as inadequate patient education and difficult-to-
access care [8–10]. MDR-TB differs from DS-TB, however, with
regard to both the prior treatment experience of the patients
[11] and the increased difficulty and longer duration of the
treatment regimen. Risk factors for default among patients
treated for MDR-TB, particularly socioeconomic and
substance-abuse risk factors and risk factors in rural
communities, are incompletely characterized.
Because of the required injections and the high pill burden,
MDR-TB treatment is commonly initiated in the inpatient
setting. Once patients are stabilized and have sputum that is
smear-negative for Mycobacterium tuberculosis, and often after
injectable medications are completed, patients are transitioned
to the outpatient setting to complete more than a year of
additional therapy. The inpatient and ambulatory settings
create different sets of obstacles for patient adherence:
ambulatory treatment disrupts patients’ lives less than
hospitalization, but it requires their active participation and
exposes them to competing pressures of family, livelihood, and
substance use [12]. Additionally, the transition from inpatient to
outpatient treatment may be a time of increased risk of loss to
follow up, as has been observed for DS-TB in Moldova [13]. In
this study, we sought to identify baseline risk factors for default
from MDR-TB treatment and determine when during the
treatment course default is most likely to occur, with special
attention to the transition period between inpatient and
outpatient treatment settings.
Methods
Ethics Statement
The study protocol was approved by the Health Research
Ethics Committee, Stellenbosch University, the Institutional
Review Board of Boston University Medical Campus, and the
Office of Human Research Administration, Harvard School of
Public Health (exemption granted of additional review). The
approving IRBs specifically waived the requirement of patient
consent for information from their clinical records to be placed
into a de-identified research database.
Study Population
We conducted a retrospective cohort study of all adult
patients (age > 15 years) who initiated MDR-TB treatment at
Brewelskloof Hospital (BKH), the TB referral hospital for the
Cape Winelands East and Overberg districts, Western Cape
Province, South Africa, between 1 January 2007 and 31
December 2010. BKH serves a largely rural, agricultural
population of approximately 600,000 people, and TB is one of
the top three causes of death in all the region’s subdistricts,
with 6714 cases of TB in 2008 and 74 cases of MDR-TB in
2008-09 [14]. Patients diagnosed with MDR-TB at general
hospitals, local clinics, or mobile clinics in this region were
referred to BKH to initiate treatment. MDR-TB was defined as
infection with disease caused by M. tuberculosis resistant to
both isoniazid and rifampin, as determined by culture-based or
molecular-based (Genotype MTBDRplus line probe assay)
susceptibility testing.
At BKH, standard care for MDR-TB patients included
hospitalization for the first four to five months of a 24-month
treatment course. While in hospital, patients without
contraindication to aminoglycosides received kanamycin
injections, in addition to oral therapy of pyrazinamide,
ethionamide, ofloxacin, and either ethambutol or terizadone.
Patients remained in hospital until their sputum was smear and
culture negative for two consecutive months, typically for a
minimum of four months, although some early discharges were
arranged for personal or disciplinary reasons. Patients then
continued oral treatment as outpatients, typically at the health
clinics where they were diagnosed. Depending on the distance
between patients' homes and clinic, patients either went to
clinic daily for directly-observed therapy (DOT), received
medications every one to two weeks at clinic with community
workers visiting their homes between clinic visits for home-
based DOT, or, if they were particularly far from a clinic,
received medications monthly from a mobile clinic and were not
routinely linked to a community health worker. Care at clinics
was carried out by nurses and supervised by BKH doctors who
visited monthly.
Data collection
Both hospital and outpatient clinic records for all MDR-TB
patients were maintained in a central office at BKH. BKH
doctors collected social and economic variables on admission
as part of their standard patient-history template. We
abstracted hospital and clinic records in a de-identified manner
using a standardized form for the following baseline variables:
patient age, gender, race, height, and weight; human
immunodeficiency virus (HIV) status, CD4 count, and
antiretroviral therapy (ART) use; comorbid psychiatric disease
and diabetes mellitus; recent alcohol, tobacco, and illicit drug
use; marital status; employment status and type of
employment; location of residence (in town versus on a farm),
type of housing, and presence of electricity, running water, and
toilet in the home; prior TB history including outcomes of
previous treatment; and patients' current MDR-TB status
including sputum collection dates and results, site(s) of
disease, the clinic making the MDR-TB diagnosis and referral,
dates of hospital admission and discharge, treatment regimens
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and dates, and final outcome with associated date.
Subsequent, post-baseline measurements of these variables
were not recorded. Employment was classified as “steady” if
the patient was employed in a year-round (as opposed to a
seasonal or day-labor) position or was a full-time student.
Housing was classified as formal (a building of durable
materials at an official address) or informal (a shack or shanty
in a backyard or informal settlement), as the terms are used in
South African housing surveys [15]. Alcohol, drug, and tobacco
use were positive if there was recent use as recorded by the
physician at intake.
Outcomes were classified according to standard definitions
[16]: cure or treatment completion required completion of
prescribed therapy with or without microbiological confirmation
of cure, respectively; default occurred if a patient missed two
consecutive months of therapy for any reason, and was dated
from the first day of the treatment interruption; outcome was
death if a patient died of any cause while receiving MDR-TB
treatment; failure occurred if a patient had persistently-positive
culture results late in treatment, or if treatment was stopped
early due to poor response or second-line drug resistance; and
final outcome was transfer if a patient moved to another
reporting and recording unit and the outcome of treatment was
unknown.
Statistical Methods
We compared baseline patient characteristics between
outcome groups, grouping cure with treatment completion and
grouping death with failure in order to focus on default (Table
1). Age, body mass index, CD4 count, years of schooling, and
time from sputum collection to treatment initiation were
analyzed as continuous variables, and other variables were
categorical.
We then examined baseline risk factors for time to default in
univariable and multivariable Cox proportional hazard
Table 1. Baseline characteristics of MDR-TB patients initiating treatment at Brewelskloof Hospital 2007-2010, overall and
stratified by outcome category.
Variable All outcomes Na Outcome categoryb Pc
   
Cure or Treatment
Completion(N=113d) Default(N=61d)Death or Failure(N=43d) 
Age (years, mean ± SD) 37.5± 11.9 225 38.1 ± 12.2 34.7 ± 10.5 40.7 ± 12.5 0.03
Female (N (%)) 98 (44%) 225 54 (48%) 25 (41%) 17 (40%) 0.54
Coloured (N (%)) 174 (77%) 225 87 (77%) 52 (85%) 31 (72%) 0.24
Married (N (%)) 56 (26%) 219 37 (34%) 9 (15%) 8 (20%) 0.02
Formal dwelling (N (%)) 154 (77%) 199 90 (88%) 35 (69%) 27 (69%) 0.004
Water, toilet, and electricity in dwelling (N (%)) 116 (73%) 160 68 (80%) 26 (67%) 21 (62%) 0.08
Town (non-farm) address (N (%)) 154 (69%) 223 81 (72%) 35 (58%) 33 (77%) 0.09
Diagnosed at mobile clinic (N (%)) 19 (8%) 224 10 (9%) 9 (15%) 1 (2%) 0.10
Education (years, median (Q1, Q3)) 7 (4, 10) 203 8 (5, 10) 7 (4, 9) 7 (4, 9) 0.23
Employed (N (%)) 135 (64%) 212 69 (66%) 37 (62%) 26 (63%) 0.83
Steady employment (non-seasonal job, or student) (N (%)) 51 (24%) 212 32 (31%) 7 (12%) 11 (27%) 0.02
Recent alcohol use (N (%)) 134 (63%) 214 57 (54%) 47 (78%) 27 (63%) 0.01
Recent tobacco use (N (%)) 157 (73%) 215 72 (67%) 50 (85%) 32 (74%) 0.05
Recent illicit drug use (N (%)) 26 (13%) 203 7 (7%) 14 (25%) 4 (10%) 0.005
Current is first known TB episode (N (%)) 30 (13%) 225 15 (13%) 7 (11%) 4 (9%) 0.78
Prior default from TB treatment (N (%)) 49 (22%) 225 21 (19%) 18 (30%) 8 (19%) 0.21
Initial sputum smear AFB positive (N (%)) 87 (43%) 204 45 (42%) 23 (46%) 16 (39%) 0.80
Extrapulmonary TB disease (N (%)) 25 (11%) 220 9 (8%) 2 (3%) 12 (29%) <.001
BMI (m2/kg) 18.8 ± 3.8 184 19.2 ± 4.2 18.4 ± 3.0 18.0 ± 3.7 0.21
HIV positive (N (%)) 70 (32%) 222 30 (27%) 12 (20%) 24 (56%) <.001
CD4 count 141 (57, 273) 66/70 219 (88, 296) 199 (98, 489) 69 (39, 116) 0.01
On ARVs at MDR-TB treatment initiation (N (% of HIV
infected)) 13 (19%) 70/70 8 (27%) 1 (8%) 3 (7%) 0.25
Diabetes mellitus at baseline (N (%)) 8 (4%) 223 6 (5%) 1 (2%) 0 (0%) 0.17
Psychiatric comorbidity (N (%)) 7 (3%) 225 5 (4%) 1 (2%) 1 (2%) 0.57
Days from sputum collection to MDR treatment initiation 65 (42, 94) 224 68 (51, 92) 67 (41, 117) 55 (32, 78) 0.07
a Total number of patients with available (non-missing) data for variable
b Transferred patients are excluded from this analysis.
c P value is calculated for three-way comparison between “cure or treatment completion”, “default”, and “death or failure” groups, using ANOVA, Kruskal-Wallis rank sum, or
Pearson’s Chi-square tests as appropriate.
d Some values were missing for some variables.
doi: 10.1371/journal.pone.0083480.t001
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regression models. Time was measured from the first day of
MDR treatment. Defaults were modeled as events, and other
final outcomes were censored when they occurred. We verified
proportional hazards assumptions by confirming that
interactions between each covariate and time on treatment
were not statistically significant, and by visual inspection of
graphs of log(-log(survival)) versus log(time) stratified by each
categorical variable. To generate a multivariable proportional
hazards regression model for time to default, we considered all
variables that were associated with default at P < 0.2 in
univariate analysis, and we retained variables that were
associated with default at P < 0.1 when added to the
multivariate model. To account for missing data, we performed
regression analyses using fivefold multiply-imputed datasets
generated by Markov chain Monte Carlo methods (SAS MI
procedure; SAS Institute), then pooled effect estimates across
datasets [17].
To examine how the default rate changed over time and how
the relationship between default and risk factors varied during
treatment, we calculated default rates for three time periods:
during hospitalization, within two months of discharge (“the
early outpatient period”), and from two months after discharge
until termination of treatment (“the late outpatient period”). We
calculated these default rates for all patients and also when
stratified by variables which we hypothesized would negatively
impact treatment adherence in the outpatient setting: baseline
recent alcohol use, whether the MDR-TB diagnosis was made
in a stationary or mobile clinic, and whether the patient’s
primary address was in town (indicating proximity to a local
health clinic) versus a farm address (indicating a longer
distance from routine TB care). We used tests of homogeneity
to examine whether the associations between these risk factors
and default differed by different treatment time periods (i.e.,
during hospitalization, the early outpatient period, and the late
outpatient period).
We performed all statistical analyses using SAS version 9.3.
Results
MDR-TB patient characteristics
We identified 225 MDR-TB patients who started treatment for
MDR-TB at BKH between 1 January 2007 and 31 December
2010. MDR-TB was confirmed by culture or molecular
resistance testing in 223 patients; two additional patients
received empiric treatment based on previous culture history.
Thirty-two percent of patients had HIV co-infection (Table 1).
Thirty-six percent were unemployed at time of MDR-TB
treatment enrollment, 24% had steady employment, and 40%
worked seasonally or as day-laborers. Sixty-three percent of
patients reported recent alcohol use, and 13% reported recent
use of illicit drugs, typically marijuana or mandrax (the
sedative-hypnotic methaqualone, mixed with marijuana and
smoked). Eighty-three percent of patients had previously been
treated for DS or DR TB, and 22% were known to have
previously defaulted from TB treatment. Seventy-seven percent
of patients were of Coloured (mixed ancestry) ethnicity, 22%
were Black African, and two patients were White. Black
patients were more likely than Coloured patients to be HIV
infected (67% versus 22%) and live in informal housing (44%
versus 17%); they were less likely than Coloured patients to
use alcohol (41% versus 68%) or tobacco (44% versus 81%)
(all p<0.01).
Treatment outcomes and associated characteristics
Half of patients were either cured (86 patients, 38%) or
completed treatment (27 patients, 12%). Sixty-one patients
(27%) defaulted, 32 (14%) died during treatment, 11 (5%)
failed treatment, and 8 (4%) transferred out. Comparisons of
baseline characteristics between outcome groups are shown in
Table 1.
With monthly sputum monitoring, 203 patients converted to
negative sputum culture on treatment, and the mean time to
first culture-negative sputum was 60 ± 47 days. Among the
patients who defaulted, the sputum of fifty-four patients (89%)
tested negative by culture before default, four patients (7%)
remained positive by culture throughout MDR treatment for a
median of 5 months (range 1 to 10 months) prior to defaulting,
and three patients (5%) defaulted early before a second
sputum was collected.
Risk factors for default
Univariate risk factors for default included alcohol, tobacco,
and illicit drug use, younger age, unmarried status, lack of
steady employment, informal dwelling, rural address, and
diagnosis of MDR-TB at a mobile clinic (Table 2). In
multivariable analysis, recent alcohol use (hazard ratio
(HR)=2.1 [95% CI 1.1-4.0], P=0.02), recent drug use (HR=2.0
[1.0-3.6], P=0.03), and Coloured ethnicity (HR=2.3 [1.1-5.0],
P=0.04) were risk factors for default, while formal housing
(HR=0.38 [0.19-0.78], P=0.01), steady employment (HR=0.41
[0.19-0.90], P=0.03), and older age (HR=0.97 [0.94-0.99] per
year of greater age, P=0.01), were associated with a lower rate
of default (Table 2).
Drug, alcohol, and tobacco use were intercorrelated (all
associated pairwise with P<0.001), but alcohol use and drug
use were independently associated with default. Although we
found no statistically significant interaction between any
covariate and time on treatment, visual inspection of graphs of
the log(-log(survival)) versus log(time) suggested possible
violations of the proportional hazards assumption for alcohol
use as well as for MDR-TB diagnosis at a mobile clinic.
Timing of default
Patients with outcomes of cure or treatment completion
received median 739 (IQR 714-768) total days of treatment and
were discharged from the hospital after median 127 (IQR
117-175) days. For patients who defaulted, median time to
default was 257 days (interquartile range (IQR) 126-363 days).
Of the 61 patients who defaulted, 15 (25%) defaulted during
hospitalization–for example, by refusing further treatment or by
failing to return from weekend leave. The default rate increased
after discharge, and patients defaulted during the early
outpatient period at 1.7 times the overall average default rate,
although as discussed further below, no increased rate of
default after discharge was seen in patients who had denied
Risk Factors for MDR-TB Treatment Default
PLOS ONE | www.plosone.org 4 December 2013 | Volume 8 | Issue 12 | e83480
recent alcohol use (Figure 1). Only one patient defaulted after
the eighteenth month of treatment.
Effect modifiers of post-discharge default risk
The relative risk of default associated with alcohol use varied
with the hospitalization status (P=0.07 for test for
homogeneity). During the in-hospital period, default rates were
comparable among those who did and did not report recent
alcohol use, but those with recent reported use at baseline
defaulted nearly four times as frequently as nonusers during
the early outpatient period and continued to default more
frequently than nonusers during the late outpatient period
(Figure 1). Among patients who did not report recent alcohol
use, the default rate declined after the initial, in-hospital period.
Table 2. Single- and multivariable proportional-hazard
regression models of default from MDR-TB treatment.
Baseline variable
Hazard ratio (95%
CI) in univariate
analysis P
Hazard ratio (95%
CI) in
multivariable
model P
Recent illicit drug use 2.78 (1.48, 5.22) 0.001 2.02 (1.04, 3.95) 0.04
Recent alcohol use 2.24 (1.22, 4.13) 0.01 2.11 (1.11, 4.02) 0.02
Steady employment (non-
seasonal job, or student) 0.37 (0.17, 0.80) 0.01 0.41 (0.19, 0.90) 0.03
Married 0.42 (0.21, 0.84) 0.01   
Formal dwelling 0.48 (0.25, 0.91) 0.03 0.38 (0.19, 0.78) 0.01
Age, per year of older age 0.98 ( 0.96, 1.00) 0.05 0.97 (0.94, 0.99) 0.01
Diagnosed at mobile clinic 2.00 (0.99, 4.07) 0.05   
Recent tobacco use 2.02 (1.01, 4.05) 0.05   
Town (non-farm) address 0.61 (0.37, 1.02) 0.06   
Prior default from TB
treatment 1.66 (0.95, 2.87) 0.07   
BMI (per m2/kg) 0.94 (0.87, 1.01) 0.11   
HIV infected 0.61 (0.32, 1.14) 0.12   
Coloured ethnicity 1.72 (0.85, 3.49) 0.13 2.24 (1.03, 4.87) 0.04
Water, toilet, and electricity
in patient’s dwelling 0.63 (0.33, 1.20) 0.17   
Education (per year of
schooling) 0.97 (0.90, 1.03) 0.30   
Diabetes mellitus 0.36 (0.05, 2.69) 0.31   
Female 0.82 (0.49, 1.36) 0.44   
Initial sputum smear AFB
positive at time of MDR-TB
diagnosis
1.15 (0.67, 2.01) 0.60   
Number of prior TB
episodes (per prior
episode)
0.94 (0.72, 1.22) 0.64   
Current MDR-TB episode
is patient’s first known TB
episode
0.89 (0.40, 1.95) 0.76   
Employed (any
employment) 0.95 (0.55, 1.62) 0.84   
doi: 10.1371/journal.pone.0083480.t002
We also investigated whether patients with a farm address
(versus a town address) or those who were diagnosed with
MDR-TB at a mobile clinic (versus a hospital or local clinic)
experienced higher rates of default after hospital discharge,
since these patients may have more difficulty accessing care
due to longer distances to health facilities and often do not
receive daily DOT. In the early outpatient period, patients who
had been diagnosed at mobile clinics defaulted at a seven
times greater rate than other patients. This higher rate of
default was confined to the early outpatient period (P=0.08 for
test of homogeneity). We did not find any association between
reporting recent alcohol use and being diagnosed at a mobile
clinic (Pearson’s Chi-square P=0.58). Although having a farm
address was associated with default in univariable analysis
(Table 1), we did not detect effect modification by time relative
to hospital discharge (P=0.41 for test of homogeneity).
Discussion
In our rural South African MDR-TB cohort, 27% of patients
defaulted from treatment before completing a full 24-month
course ‒ twice the 12-15% average default rate in published
MDR-TB cohorts worldwide [18–20]. The high default rate we
observed remains comparable to previously-observed South
African MDR-TB treatment default rates of 29% in an urban
Western Cape TB hospital in 1992-2002 [21] and of 21% in
high-HIV-prevalence regions in 2000-2004 prior to antiretroviral
availability [3,4]. Even if MDR-TB mortality and treatment
failure decline with improved diagnostics, drugs, and other
medical care, the 2015 target treatment success rate of 75%
will remain unattainable unless these high rates of default also
improve [1]. Recent South African MDR-TB guidelines
recommend post-hoc interventions (psychological evaluations,
substance abuse rehabilitation programs, or transportation or
food aid) for patients who have demonstrated poor treatment
compliance for corresponding reasons [22], but it would be
preferable to allocate these resources effectively before
defaults occur. Our findings demonstrate that certain socially-
unstable patients are at risk for default and could benefit from
adherence-focused interventions throughout their treatment. In
addition, the association we found between alcohol use and
post-discharge default highlights a patient population at
particular risk as MDR-TB treatment delivery moves
increasingly to the outpatient setting.
Alcohol is known to be associated with developing active TB,
as well as with poor clinical outcomes including drug
resistance. Alcohol is also associated with default from
treatment of DS TB, likely because of social destabilization
caused by alcoholism, but possibly also in part because alcohol
magnifies medication toxicities [23]. The few other MDR-TB
cohorts to report substance use data have also noted
substance use as a risk factor for treatment default: alcohol
abuse was a risk factor in Eastern Europe [24,25], and
substance (drug and/or alcohol) use was a risk factor in Peru
and South Africa [6,26]. Our findings go further in
demonstrating that a history of alcohol use may be especially
predictive of default during the outpatient portion of treatment.
We also show alcohol and drug use to be independent risk
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factors even after controlling for available socioeconomic
variables. Alcohol use is prevalent in the Western Cape [27],
and hospital-enforced abstinence may enhance initial treatment
retention among alcohol users. Patients who use alcohol
should be followed closely during the transition from hospital to
outpatient treatment to ensure that they establish care with
local clinics. Although financial supports such as free food and
transportation reimbursement alone may not increase
adherence in alcoholics [25], integrating medical or behavioral
treatment of alcoholism into TB care has been shown to
improve treatment adherence for some alcohol-using patients
[28]. Drug use, although less common than alcohol use in our
study population, may increase default by similar mechanisms
and may be amenable to similar interventions.
The association we found between informal housing and
default agrees with previous identification of substandard
housing conditions in Peru [6] and unstable residence in a five-
province South African sample [26] as risk factors for MDR-TB
treatment default – although the Peruvian study, which
provided extensive social, financial, and psychiatric supports,
had a much lower overall default rate of 10% [6]. In addition,
we found that patients without steady employment, many of
whom are seasonal farm workers in our study setting, are also
at risk. To retain younger patients and patients with competing
basic socioeconomic needs in care for the duration of MDR-TB
treatment, targeted interventions to consider include
community health worker support, DOT, and comprehensive
financial support packages, all of which have demonstrated
effectiveness [18].
We did not find associations between default and HIV or
prior TB treatment. Although HIV was previously noted as a
risk factor for default in South Africa prior to widespread
antiretroviral treatment [3], HIV was associated with death but
not default in our cohort, perhaps because many of these
patients are also connected to the public health system for HIV
as well as TB care. Prior default has been predictive of
repeated default from DS-TB treatment [9,29], and although we
saw some evidence of a similar trend in MDR-TB patients, the
association was not significant in multivariable analysis and
appears to be largely accounted for by other measurable risk
factors such as substance use and employment status.
The elevated default rates we observed in the two months
immediately after discharge highlight the transition period
between the inpatient and outpatient treatment settings as a
high-risk time for MDR-TB treatment adherence. The increased
rate of default in that period appears to be driven by individuals
with a history of recent alcohol use. Also, although the sample
size of patients using mobile clinics was small, having been
diagnosed at a mobile clinic was also associated with a greater
risk of default in the early outpatient period, and this
association did not appear to be explained by alcohol use.
South African guidelines recommend but do not require DOT
Figure 1.  Default rates for patients on MDR-TB treatment, by time period and alcohol use status.  Default rates with 95%
confidence intervals were calculated in each of three time periods defined relative to hospital discharge date. Rates are shown for
all patients as well as stratified by reported history of recent alcohol use.
doi: 10.1371/journal.pone.0083480.g001
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beyond the intensive phase of therapy [22], and at the time of
this study, most patients treated by mobile clinics did not
receive daily DOT, which could facilitate the transition to
outpatient care. Although high default rates following discharge
have not been previously described for MDR-TB, a similar
increase in default rates after discharge from the in-hospital,
intensive treatment phase was reported among DS-TB patients
in Moldova[13].
We note limitations to this study. Drug, tobacco, and alcohol
use at intake were available for nearly all patients, but use was
not quantified nor re-evaluated later during care. Quantification
could help identify a threshold at which alcohol and drug use
are problematic for adherence. It is known that drinking in this
region tends to involve binging rather than moderate social
use, and therefore, reported alcohol use often indicates abuse.
In one survey of farm workers in the region, 87% screened
positive for problem drinking by the CAGE questionnaire [27].
Women drink heavily as well; in a household survey, 68% of
women who drank were classified as high-risk drinkers by the
Alcohol Use Disorders Identification Test (AUDIT) scale [30].
Had we been able to distinguish between high-risk and more
moderate alcohol use, we may have observed a stronger
association between high-risk alcohol use and default than that
which we observed for any recent alcohol use.
We were unable to enroll or quantify those patients
diagnosed with MDR-TB who never started treatment. Only
44% of the South African patients who were diagnosed with
MDR-TB in 2011 initiated treatment [31], and the risk factors for
never entering care may differ from the risk factors for starting
but not completing treatment. We also cannot determine
whether associations we observed were causal, although these
associations are mechanistically plausible. Lastly, we had
limited information about patients’ access to clinics; we used
farm addresses and mobile clinic diagnoses as proxies for
longer distances to clinic. Precise travel times to clinic and data
about frequency of health worker contact would help clarify the
extent to which proximity to health clinics affects default.
Default is a major barrier to cure in MDR-TB patients, and in
this rural farming population, younger patients, economically-
unstable patients, patients receiving care from mobile clinics,
and alcohol and drug users are particularly at risk for default.
Socioeconomic supports targeting the most at-risk groups may
help to increase treatment adherence in the Western Cape and
similar areas of high MDR-TB burden. Also, although outpatient
treatment may be easier, more affordable, and better for
patients in the long run, the transition from in-hospital to
community-based treatment is a difficult period in which extra
care must be taken to prevent default. Because of alcohol-
using patients’ higher default rate during the transition period
and in the outpatient setting, MDR-TB programs should assess
alcohol use patterns in their patient populations and consider
following and supporting alcohol-using patients more
intensively.
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